These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2962438)

  • 41. Colchicine treatment of cirrhosis: answers.
    Kershenobich D; Vargas F; Garcia-Tsao G; Tamayo RP; Gent M; Rojkind M
    Hepatology; 1989 Apr; 9(4):656-7. PubMed ID: 2925170
    [No Abstract]   [Full Text] [Related]  

  • 42. Colchicine treatment of cirrhosis: questions.
    Grace ND
    Hepatology; 1989 Apr; 9(4):655-6. PubMed ID: 2925169
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis.
    Kilic ZM; Kuran S; Akdogan M; Cicek B; Oguz D; Odemis B; Sasmaz N
    Adv Ther; 2008 Mar; 25(3):190-200. PubMed ID: 18385953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
    Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C
    Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
    Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
    Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats.
    Favari L; Pérez-Alvarez V
    Arch Med Res; 1997; 28(1):11-7. PubMed ID: 9078581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Protective effect of colchicine on tissue damage caused by free radicals in hepatic cirrhosis: an experimental study in rats].
    Rhoden EL; Mauri M; Petteffi L; Belló-Klein A; Zettler CG; Rhoden CR
    Arq Gastroenterol; 1997; 34(2):91-6. PubMed ID: 9496424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dose-dependent acute effect and long-term modification by molsidomine of portal and cardiac hemodynamics in patients with liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():65-8, 76. PubMed ID: 7968910
    [No Abstract]   [Full Text] [Related]  

  • 50. Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.
    Cetin K; Sabahattin K; Kadir D; Ahmet D; Ziyaettin D; Selim B; Mürüvvet B; Fatih B; Güngör B; Zeynel M; Yilmaz C; Atilla O
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcv-ccxcvii. PubMed ID: 15244206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical observation of recombinant growth hormone therapy for liver cirrhosis with hypoproteinemia].
    Liu SJ; Tang WL; Shen SR
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):398-400. PubMed ID: 14653129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy of active cirrhosis with penicillamine].
    Schnack H
    Wien Med Wochenschr; 1971 Dec; 121(49):900-2. PubMed ID: 5130380
    [No Abstract]   [Full Text] [Related]  

  • 53. [Possible clinical cure in a high percentage of cases of liver cirrhosis with a treatment based on high doses of testosterone and vitamin B 1 ].
    Girolami M
    Minerva Med; 1973 May; 64(30):1567-623. PubMed ID: 4577116
    [No Abstract]   [Full Text] [Related]  

  • 54. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Focal cirrhosis of the liver].
    Pyshkin SA; Borisov DL; Gorfinkel' AN; Efremova EV; Iuskin IA
    Khirurgiia (Mosk); 2005; (10):46-9. PubMed ID: 16247407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colchicine in the treatment of hepatic fibrosis in children.
    Koçak N; Yüce A; Gürakan F; Ozen H; Göğüş S; Kale G; Cağlar M
    Am J Gastroenterol; 1996 Jan; 91(1):179-80. PubMed ID: 8561135
    [No Abstract]   [Full Text] [Related]  

  • 57. [Liver ultrastructure in primary biliary cirrhosis].
    Koch OR; Findor JA; Bruch Igartua E; Arias RM
    Medicina (B Aires); 1980; 40(3):253-62. PubMed ID: 7432145
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colchicine reduces hepatic fibrosis in mice infected with Schistosoma japonicum.
    Jiang J; Zhong C; Yu Y; Zhang Q
    Chin Med J (Engl); 1996 Oct; 109(10):795-800. PubMed ID: 9275358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.